Salih, Helmut R.
German Cancer Research Center · Universitätsklinikum Tübingen · Deutsches Konsortium für Translationale Krebsforschung · University of Tübingen
6 papers on CoChatORCID 0000-0002-6719-1847
Most cited papers
- Verified
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine
Retinoids in leukemia and cellular processesAcute Myeloid Leukemia Research
Cited by 1,611
- Verified
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology
vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research
Cited by 582
- Verified
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., et al. (2019) · Nature
Immune Cell Function and InteractionAcute Myeloid Leukemia Research
Cited by 391
- Verified
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
Hinterleitner, C., Strähle, J., Malenke, E., Hinterleitner, M., Henning, M., Seehawer, M., Bilich, T., Heitmann, J., Lutz, M., Mattern, S., et al. (2021) · Nature Communications
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 175
- Verified
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., Krämer, A., Root, D. E., Barbie, D. A., Krivtsov, A. V., et al. (2014) · Blood
Acute Myeloid Leukemia ResearchChromatin Remodeling and Cancer
Cited by 170
- Verified
The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors
Schwarzbich, M.-A., Gutknecht, M., Salih, J., Salih, H. R., Brossart, P., Rittig, S. M., & Grünebach, F. (2012) · Cancer Immunology, Immunotherapy
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free